EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
85 hedge funds and large institutions have $124M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 19 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $151M → $124M (-$26.9M)
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
Holders
85
Holding in Top 10
3
Calls
$301K
Puts
$267K
Top Buyers
| 1 | +$5.89M | |
| 2 | +$1.61M | |
| 3 | +$1.16M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$934K |
| 5 |
6CM
683 Capital Management
New York
|
+$649K |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$1.43M | |
| 3 | -$888K | |
| 4 |
DC
Davenport & Co
Richmond,
Virginia
|
-$734K |
| 5 |
Two Sigma Advisers
New York
|
-$402K |